Page last updated: 2024-10-21

n-(3-(aminomethyl)benzyl)acetamidine and Disease, Pulmonary

n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Disease, Pulmonary in 2 studies

N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rudkowski, JC1
Barreiro, E1
Harfouche, R1
Goldberg, P1
Kishta, O1
D'Orleans-Juste, P1
Labonte, J1
Lesur, O1
Hussain, SN1
Brown, C1
Selig, WM1
Ellis, JL1

Other Studies

2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Disease, Pulmonary

ArticleYear
Roles of iNOS and nNOS in sepsis-induced pulmonary apoptosis.
    American journal of physiology. Lung cellular and molecular physiology, 2004, Volume: 286, Issue:4

    Topics: Acute Disease; Amidines; Animals; Apoptosis; Benzylamines; Caspases; Enzyme Inhibitors; Lipopolysacc

2004
Modulation of citric acid-induced cough following lipopolysaccharide-mediated neutrophilia in the guinea pig.
    Pulmonary pharmacology & therapeutics, 2007, Volume: 20, Issue:1

    Topics: Administration, Inhalation; Aerosols; Amidines; Animals; Anti-Inflammatory Agents; Benzylamines; Bro

2007